Ozempic and Your Brain — What the Science Says

Join Dr. Ben Synth as he cuts through the hype to explore the neuroscience behind Ozempic and GLP-1 drugs—far beyond weight loss. Discover how these medications may rewire brain circuits tied to addiction, potentially protect against Alzheimer's, and transform emotional responses in ways researchers are only beginning to understand.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores how Ozempic affects mood and cognition through serotonin and dopamine systems. While large studies show psychiatric safety, individual responses vary dramatically. Research reveals promising links between gut health, brain inflammation, and mental wellness—suggesting weight-loss drugs may revolutionize how we understand depression treatment.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Join AI host Ben Synth as he examines research suggesting semaglutide (Ozempic) may reduce Alzheimer's risk by up to 33%. Drawing from studies of over 100 million patient records, Ben explores four mechanisms—neuroinflammation reduction, improved vascular function, amyloid plaque control, and enhanced neuroplasticity—while carefully distinguishing promising observational data from proven causation.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.